Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …

Mass spectrometry (MS), a core technology for proteomics and metabolomics, is currently
being developed for clinical applications. The identification of microorganisms in clinical …

Background Multidrug-resistant (MDR) bacteria that are commonly associated with health
care cause a substantial health burden. Updated national estimates for this group of …

Early diagnosis of severe infections requires of a rapid and reliable diagnosis to initiate
appropriate treatment, while avoiding unnecessary antimicrobial use and reducing …

Rapid diagnosis and treatment application in the early stages of H. pylori infection plays an
important part in inhibiting the transmission of this infection as this bacterium is involved in …

The available literary data suggest the general applicability and benefits of the Matrix-
assisted laser desorption/ionization (MALDI) time-of-flight (TOF) mass spectrometry (MS) in …

Bloodstream infections (BSI) and sepsis are major causes of morbidity and mortality
worldwide. Blood culture-based diagnostics usually requires 1–2 days for identification of …

Even with advances in antibiotic therapies, bacterial infections persistently plague society
and have amounted to one of the most prevalent issues in healthcare today. Moreover, the …

Species identification by using matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS) is a routine diagnostic process for infectious diseases in …

Background Administration of appropriate antimicrobial therapy is one of the key factors in
surviving bloodstream infections. Blood culture is currently the reference standard for …